drugset / Trial / NCT02805049
Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis (EPI Study)
NaSingle-groupOpen-labelTreatment
Summary
The main objective of this study is to describe the pharmacokinetics of the prescribed echinocandins for septic shock with secondary peritonitis for which intra-abdominal fungal infection is suspected or proven.
Timeline
- Start
- 2017-01-28
- Primary completion
- 2018-06-18
- Completion
- 2018-06-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Caspofungin | Other / unclassified | — | — |
| Subject | Micafungin | Peptide | 100 mg | — |